AXT Inc
AXTI
79.79
-4.27
-5.08%
AXT Inc
US · AXTI
#1999 by market cap
Listed 1970
79.79
-4.27
-5.08%
Live - 5344 symbols - heartbeat 254s ago
· 2026-10-08 08:30
Pre-market
77.10
-3.37%
After-hours
80.44
+0.81%
Overnight
77.60
-2.74%
- Market cap
- 5.23B
- P/E (TTM)i
- 2,659.67
- P/Bi
- 5.92
- EPSi
- -0.49
- Div yieldi
- 0.00%
- 52W posi
- 54%
Reader sentiment
Are you bullish or bearish on AXTI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 31.94, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -11.11% YoY
Margins
- Gross margin
- 12.73%
- Operating margin
- -23.34%
- Net margin
- -24.27%
Key ratios & quality
- Altman Z-Scorei
- 31.94
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 102.40M | 83.26M | 95.36M | 137.39M | 141.12M | 75.80M | 99.36M | 88.33M |
| Gross profit | 37.05M | 24.83M | 30.28M | 47.41M | 52.12M | 13.32M | 23.84M | 11.24M |
| Selling & admin expenses | 19.00M | 19.31M | 19.20M | 24.19M | 25.65M | 22.81M | 24.10M | 24.17M |
| Research & development | 5.90M | 5.83M | 7.14M | 10.33M | 13.91M | 12.08M | 14.54M | 9.05M |
| Operating profit | 12.15M | 494.00K | 7.74M | 14.02M | 14.26M | -19.01M | -12.56M | -20.62M |
| Pretax profit | 11.95M | -1.03M | 7.07M | 17.60M | 20.93M | -19.03M | -10.66M | -21.54M |
| Tax | 938.00K | 562.00K | 2.03M | 1.09M | 2.19M | 160.00K | 1.13M | 1.66M |
| Net profit | 11.01M | -1.59M | 5.04M | 16.51M | 18.74M | -19.19M | -11.79M | -23.20M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.24 | -0.07 | 0.07 | 0.34 | 0.37 | -0.42 | -0.27 | -0.49 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 19.36M | 17.97M | 27.96M | 23.04M | 26.92M | 47.59M |
| Gross profit | -1.24M | 1.43M | 6.22M | 4.83M | 7.98M | 21.37M |
| Selling & admin expenses | 5.92M | 5.65M | 6.33M | 6.27M | 6.55M | 7.29M |
| Research & development | 3.12M | 2.53M | 1.01M | 2.39M | 3.01M | 3.65M |
| Operating profit | -10.28M | -6.75M | -1.12M | -2.47M | -1.59M | 10.42M |
| Pretax profit | -9.94M | -7.10M | -1.17M | -3.34M | -1.06M | 15.13M |
| Tax | 74.00K | 579.00K | 504.00K | 501.00K | 430.00K | 2.10M |
| Net profit | -10.02M | -7.67M | -1.67M | -3.84M | -1.49M | 13.03M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.20 | -0.16 | -0.04 | -0.08 | -0.03 | 0.17 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 128.54M | 113.21M | 164.52M | 160.19M | 183.55M | 170.66M | 158.27M | 246.56M |
| Cash & ST investments | 38.66M | 36.32M | 72.84M | 42.18M | 44.29M | 39.89M | 22.83M | 120.27M |
| Inventory | 58.57M | 49.15M | 51.52M | 65.91M | 89.63M | 86.50M | 85.08M | 81.65M |
| Total assets | 223.52M | 223.35M | 298.86M | 332.44M | 370.07M | 358.70M | 339.31M | 433.75M |
| Total current liabilities | 28.71M | 27.53M | 39.08M | 47.82M | 75.33M | 81.56M | 74.18M | 90.54M |
| Short-term debt | -- | 6.07M | 10.86M | 14.60M | 47.56M | 53.38M | 47.80M | 63.38M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 28,992,000.00 | 30,587,000.00 | 43,330,000.00 | 52,210,000.00 | 80,326,000.00 | 89,555,000.00 | 84,406,000.00 | 99,120,000.00 |
| Total equity | 194.53M | 192.76M | 255.53M | 280.23M | 289.75M | 269.15M | 254.91M | 334.63M |
| Retained earnings | -45.18M | -47.78M | -44.55M | -29.97M | -14.16M | -32.04M | -43.66M | -64.92M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 149.53M | 144.96M | 149.76M | 246.56M | 253.78M | 598.80M |
| Cash & ST investments | 31.58M | 27.01M | 23.11M | 120.27M | 107.14M | 417.20M |
| Inventory | 80.41M | 80.06M | 77.66M | 81.65M | 90.17M | 96.32M |
| Total assets | 333.48M | 329.00M | 334.03M | 433.75M | 444.60M | 1.10B |
| Total current liabilities | 75.26M | 79.54M | 84.90M | 90.54M | 97.88M | 125.66M |
| Short-term debt | 53.05M | 56.48M | 62.11M | 63.38M | 69.46M | 84.87M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 87,305,000.00 | 88,372,000.00 | 93,578,000.00 | 99,120,000.00 | 107,632,000.00 | 145,344,000.00 |
| Total equity | 246.17M | 240.63M | 240.46M | 334.63M | 336.97M | 951.85M |
| Retained earnings | -52.46M | -59.47M | -61.38M | -64.92M | -66.54M | -55.42M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 3.22M | 12.66M | 5.87M | -3.31M | -8.77M | 3.40M | -12.11M | -12.78M |
| Depreciation & amortization | 4.87M | 5.53M | 4.33M | 7.08M | 8.12M | 8.72M | 8.98M | 9.11M |
| Free cash flow | -37.32M | -9.13M | -13.99M | -32.95M | -37.23M | -7.07M | -17.88M | -18.78M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 366.00K | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 16.53M | 26.89M | 72.60M | 36.76M | 41.35M | 50.11M | 33.81M | 128.37M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -3.35M | -4.58M | -9.15M | 4.29M | -11.68M | 10.78M |
| Depreciation & amortization | 2.22M | 2.26M | 2.31M | 2.32M | 2.44M | 2.51M |
| Free cash flow | -3.86M | -4.86M | -11.33M | 1.26M | -13.06M | 3.56M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 38.18M | 35.11M | 31.21M | 128.37M | 57.87M | 445.22M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 5.16 | -1.49 | 1.64 | 7.25 | 7.34 | -8.63 | -6.06 | -9.34 |
| ROA %i | 4.36 | -1.24 | 1.17 | 4.56 | 4.45 | -4.96 | -3.38 | -5.55 |
| ROIC %i | 4.89 | -1.51 | 1.55 | 6.75 | 6.75 | -6.44 | -4.34 | -7.13 |
| 5-year avg ROE %i | 2.57 | 2.50 | 3.19 | 3.80 | 3.98 | 1.22 | 0.31 | -1.89 |
| EBIT margin %i | 11.86 | 0.59 | 8.12 | 10.21 | 15.59 | -23.10 | -9.38 | -22.97 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Current ratioi | 4.48 | 4.11 | 4.21 | 3.35 | 2.44 | 2.09 | 2.13 | 2.72 |
| Quick ratioi | 2.03 | 2.01 | 2.49 | 1.61 | 0.98 | 0.73 | 0.65 | 1.62 |
| Debt / assetsi | 0.00 | 3.92 | 4.43 | 4.98 | 13.21 | 15.54 | 14.67 | 14.94 |
| LT debt / equityi | -- | 1.46 | 1.26 | 0.93 | 0.61 | 1.17 | 1.04 | 0.53 |
| Interest coveragei | -- | -- | -- | -- | 20.54 | -11.46 | -6.95 | -16.14 |
| Revenue CAGR (3Y) %i | 9.73 | 0.78 | -1.13 | 10.30 | 19.23 | -7.37 | -10.24 | -14.46 |
| Net income CAGR (3Y) %i | -- | -- | -31.67 | 14.72 | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -9.77 | -12.90 | -12.33 | -9.34 | -6.30 | 0.73 |
| ROA %i | -5.43 | -7.08 | -6.66 | -5.55 | -3.67 | 0.54 |
| ROIC %i | -7.21 | -9.54 | -8.94 | -7.13 | -4.93 | 0.64 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -18.29 | -27.49 | -24.97 | -22.97 | -12.09 | 4.44 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 1.99 | 1.82 | 1.76 | 2.72 | 2.59 | 4.77 |
| Quick ratioi | 0.72 | 0.63 | 0.67 | 1.62 | 1.42 | 3.61 |
| Debt / assetsi | 16.47 | 17.69 | 19.07 | 14.94 | 15.92 | 7.84 |
| LT debt / equityi | 1.02 | 0.97 | 0.90 | 0.53 | 0.48 | 0.13 |
| Interest coveragei | -13.94 | -20.05 | -19.06 | -16.14 | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Substrates is the largest reported line at 78.93% of revenue, across 2 reported segments.
- The next-largest line, Raw materials and other, is a distant second at 21.07% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Substrates78.93%
Raw materials and other21.07%
Quote time 2026-10-08 08:30:19 · For reference only, not investment advice and not tailored to your situation.